New drug cizutamig enters early trial for thyroid eye disease
NCT ID NCT07597200
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial is testing a new drug called cizutamig in 38 adults with active, moderate-to-severe thyroid eye disease. The main goal is to see if the drug is safe and tolerable, while also checking how the body processes it and whether it shows any signs of helping the condition. Participants will receive the drug and be monitored closely for side effects and changes in their symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cizutamig (a drug)
- What this could lead to
- If this works, it could point toward a new treatment option for thyroid eye disease, potentially reducing symptoms like bulging eyes and discomfort.
- What could go wrong
- This is a very early Phase 1b trial with only 38 people, so it's mainly checking safety. The drug may not work well or could have side effects, and much more research is needed before it could become a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE (TED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Ninth People's hospital Shanghai Jiaotong University school of medicines
RECRUITINGShanghai, Shanghai Municipality, 200011, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your Phone's camera help track thyroid eye disease?
- New drug aims to ease bulging eyes in thyroid disease patients
- New drug MHB018A aims to reduce eye bulging in thyroid eye disease
- New shot aims to reduce bulging eyes from thyroid disease
- New pill could help when steroids fail for bulging eyes
- New drug could beat steroids for saving sight in thyroid eye disease